PCN67 Estimating Cost-Effectiveness of Pembrolizumab in Advanced Esophageal Cancer Based on the Keynote-181 Trial

Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.159
https://www.valueinhealthjournal.com/article/S1098-3015(21)00376-4/fulltext
Section Title :
Section Order : 10736
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00376-4&doi=10.1016/j.jval.2021.04.159
HEOR Topics :
Tags :
Regions :